Chan Mitchell Insider Trades

Insider Trading History

Track insider trading activity for Chan Mitchell. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Avalo Therapeutics
Avalo Therapeutics AVTX
Director
Holding Value $58.3k 3,166 shares
Last Trade
May 06, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$72.5k 3,167 shares
$22.88
$18.42
Avalo Therapeutics
Avalo Therapeutics AVTX
Director
Holding Value $58.3k 3,167 shares
Last Trade
Mar 28, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$44k 3,166 shares
$13.89
$18.42
Avalo Therapeutics
Avalo Therapeutics AVTX
Director
Holding Value $117k 6,333 shares
Last Trade
Mar 28, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$44k 3,166 shares
$13.89
$18.42
Regenxbio
Regenxbio RGNX
Chief Financial Officer
Holding Value $1.57M 127,717 shares
Last Trade
Jan 06, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.61M 113,399 shares
$14.18
$12.29
Regenxbio
Regenxbio RGNX
Chief Financial Officer
Holding Value $663k 53,968 shares
Last Trade
Sep 01, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$43.8k 4,901 shares
$8.93
$12.29
Avalo Therapeutics
Avalo Therapeutics AVTX
Director
Holding Value $370k 20,100 shares
Last Trade
Jun 17, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$89.8k 20,100 shares
$4.47
$18.42
Avalo Therapeutics
Avalo Therapeutics AVTX
Director
Holding Value $117k 6,333 shares
Last Trade
Mar 28, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$26.8k 3,167 shares
$8.46
$18.42
Avalo Therapeutics
Avalo Therapeutics AVTX
Director
Holding Value $58.3k 3,167 shares
Last Trade
Mar 28, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$26.8k 3,167 shares
$8.46
$18.42
Regenxbio
Regenxbio RGNX
Chief Financial Officer
Holding Value $769k 62,547 shares
Last Trade
Jan 02, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$492k 62,547 shares
$7.86
$12.29
Regenxbio
Regenxbio RGNX
Chief Financial Officer
Holding Value $3.56M 289,362 shares
Last Trade
Sep 16, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.69M 289,362 shares
$12.74
$12.29
Avalo Therapeutics
Avalo Therapeutics AVTX
Director
Holding Value $453k 24,600 shares
Last Trade
Aug 13, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$243k 24,600 shares
$9.88
$18.42
Avalo Therapeutics
Avalo Therapeutics AVTX
Director
Holding Value $61.4k 3,334 shares
Last Trade
Dec 20, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$34.4k 3,334 shares
$10.32
$18.42
Avalo Therapeutics
Avalo Therapeutics AVTX
Director
Holding Value $737k 40,000 shares
Last Trade
Jun 14, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$102M 80,000 shares
$1,270.08
$18.42
Avalo Therapeutics
Avalo Therapeutics AVTX
Director
Holding Value $1.47M 80,000 shares
Last Trade
Dec 01, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$431M 80,000 shares
$5,385.60
$18.42

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up